Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial

BACKGROUND: Melatonin may reduce REM‐sleep behavior disorder (RBD) symptoms in Parkinson's disease (PD), though robust clinical trials are lacking. OBJECTIVE: To assess the efficacy of prolonged‐release (PR) melatonin for RBD in PD. METHODS: Randomized, double‐blind, placebo‐controlled, paralle...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilat, Moran, Coeytaux Jackson, Alessandra, Marshall, Nathaniel S., Hammond, Deborah, Mullins, Anna E., Hall, Julie M., Fang, Bernard A.M., Yee, Brendon J., Wong, Keith K.H., Grunstein, Ron R., Lewis, Simon J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027846/
https://www.ncbi.nlm.nih.gov/pubmed/31674060
http://dx.doi.org/10.1002/mds.27886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027846/
https://www.ncbi.nlm.nih.gov/pubmed/31674060
http://dx.doi.org/10.1002/mds.27886

Ejemplares similares